Hemostatic abnormalities in inflammatory bowel disease

Thrombosis Research

Volumn 82, Issue 2, 1996, Pages 137-146

  Chiarantini, Elena ^a,b   Valanzano, Rosa ^a   Liotta, Agatina Alessandrello ^a   Cellai, Anna Paola ^a   Fedi, Sandra ^a   Ilari, Isabella ^a   Prisco, Domenico ^a   Tonelli, Francesco ^a   Abbate, Rosanna ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Clin Medica Generale e Cardiologia   (Italy)

Author keywords

coagulation; Crohn's disease; fibrinolysis; inflammatory bowel disease; ulcerative colitis

Indexed keywords

FIBRINOGEN; PROTHROMBIN FRAGMENT 1; PROTHROMBIN FRAGMENT 2; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

EID: 0029974758     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00060-6     Document Type: Article

References (42)

1. BARGEN, J.A. and BARKER, N.W. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58, 17-31, 1936.
2. EDWARDS, F.C. and TRUELOVE, S.C. The course and prognosis of ulcerative colitis. III. Complications. Gut, 5, 1-15, 1964.
3. TALBOT, R.W., HEPPELL, J., DOZOIS, R.R. and BEART, R.W. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61, 140-145, 1986.
4. SILVERSTEIN, A.P and PRESENT, D.H. Cerebrovascular occlusions in relatively young patients with regional enteritis. JAMA, 215, 976-977, 1971.
5. MAYEUX, R. and FAHN, S. Strokes and ulcerative colitis. Neurology 28, 571-574, 1978.
6. SCHNEIDERMAN, J.H., SHARPE, J.A. and SUTTON, D.M.C. Cerebral and renal vascular complications of inflammatory bowel disease. Ann Neurol 5, 331-337, 1979.
7. PRIOR, A., STRANG, F.A. and WHORWELL, P.J. Internal carotid artery occlusion in association with Crohn's disease. Dig Dis Sci 9, 1047-1050, 1987.
8. JORENS, P.G., HERMANS, C.R., HABER, I., KOCKX, M.M., VERMYLEN, J. and PARIZEL, G.A. Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis. Blut 61, 307-310, 1990.
9. WAKEFIELD, A.J., SAWYERR, A.M., DHILLON, A.P., PITTILO, R.M., ROWLES, P.M., LEWIS, A.A.M. and POUNDER, R.E. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 2, 1057-1062, 1989.
10. MOTTE, S., FLAMME, F., DEPIERREUX, M., WAUTRECHT, J.-C., VAN GOSSUM, A. and DEREUME, J.P. Venous thromboangioitis associated with regional enteritis. Int Angiol 11, 237-240, 1992.
11. LAM, A., BORDA, I.T., INWOOD, M.J. and THOMSON, S. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68, 245-251, 1975.
12. LAKE, A.M., STAUFFER, J.Q. and STUART, M.J. Hemostatic alterations in inflammatory bowel disease. Response to therapy. Am J Dig Dis 23, 897-902, 1978.
13. VECCHI M., CATTANEO, M., DE FRANCHIS, R. and MANNUCCI, P.M. Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 21, 165-170, 1991.
14. GHOSH, S., MACKIE, M.J., MC VERRY, B.A., GALLOWAY, M., ELLIS, A. and MC KAY, J Chronic inflammatory bowel disease, deep-venous thrombosis and antithrombin activity. Acta Haematol 70, 50-53, 1983.
15. AADLAND, E., ODEGARD, O.R., ROSETH, A. and TRY, K Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 27, 957-960, 1992.
16. HUDSON, M., HUTTON, R.A., WAKEFIELD, A.J., SAWYERR, A.M. and POUNDER, R.E. Evidence for activation of coagulation in Crohn's disease. Blood CoaguL Fibrinolysis 3, 773-778, 1992.
17. DE JONG, E., PORTE, R.J., KNOT, E.A.R., VERHEIJEN, J.H. and DEES, J. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and feaces. Gut 30, 188-194, 1989.
18. CONLAN, M.G., HAIRE, W.D. and BURNETT, D.A. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 34, 1089-1093, 1989.
19. WISEN, O. and GARDLUND, B. Hemostasis in Crohn's disease: low factor XIII levels in active disease. Scand J Gastroenterol 23, 961-966, 1988.
20. SUZUKI, R., TODA, H. and TAKAMURA, Y. Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut 59, 162-164, 1989.
21. STADNICKI, A., KLOCZKO, J., NOWAK, A., SIERKA, E. and SLIWINSKI, Z. Factor XIII subunits in relation to some other hemostatic parameters in ulcerative colitis. Am J Gastroenterol 86, 690-693, 1991.
22. HUDSON, M., WAKEFIELD, A.J., HUTTON, R.A., SANKEY, E.A., DHILLON, A.P., MORE, L., SIM, R. and POUNDER, R.E. Factor XIIIA subunit and Crohn's disease. Gut 34, 75-79, 1993.
23. VIANNA, J.L., D'CRUZ, D.P., KHAMASHTA, M.A., ASHERSON, R.A. and HUGHES, G.R. Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol 10, 165-168, 1992.
24. DALEKOS, G.N., MANOUSSAKIS, M.N., GOUSSIA, A.C., TSIANOS, E.V. and MOUTSOPOULOS, H.M. Soluble interleukin-2 receptors, antineutrofil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34, 658-664, 1993.
25. GREENFIELD, S.M., TEARE, J.P., WHITEHEAD, M.W. and THOMPSON, R.P. Amaurosis fugax, Crohn's disease and the anticardiolipin antibody. Lupus 2, 271-273, 1993.
26. CHAMOUARD, P., GRUNEBAUM, L., WIESEL, M.L., FREYSSINET, J.M., DUCLOS, B., CAZENAVE, J.P. and BAUMANN, R. Prevalence and significance of anticardiolipin antibodies in Crohn,s disease. Dig Dis Sci 39, 1501-1504, 1994.
27. BEST, W.R., BECKTEL, J.M., SINGELTON, J.W. and KERN, F., Jr Development of a Crohn's disease activity index. Gastroenterology 70, 439-444, 1976.
28. TRUELOVE, S.C. and WITTS, I.J. Cortisone in ulcerative colitis. Br Med J 2, 1041-1048, 1955.
29. SANIABADI, A.R, LOWE, G.D.O., MADHOK, R., SPOWART, K., SHAW, B., BARBENEL, J.C. and FORBES, C.D. Red blood cells mediate spontaneous aggregation of platelets in whole blood. Atherosclerosis 66, 175-180, 1987.
30. GRAY, R.P., HENDRA, T.J., PATTERSON, D.L.H. and YUDKIN, J.S. "Spontaneous" platelet aggregation in whole blood in diabetis survivors of acute myocardial infarction. Thromb Hemost 70, 932-936, 1993.
31. ALVING, B.N., BALDWIN, P.E., RICHARDS, R.L. and JACKSON, B.J. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants. Thromb Haemost 54, 709-712, 1985.
32. EXNER, T.E., RICKARD, K.A. and KRONBERG, H. A sensitive test demosnstrating Lupus Anticoagulant and its behavioural patterns. Br J Haematol 40, 143-151, 1978.
33. THIAGARAJAN, P., PENGO, V. and SHAPIRO, S.S. The use of dilute Russell viper venom time for the diagnosis of Lupus Anticoagulants. Blood 68, 869-874, 1986.
34. SCHLEIDER, M.A., NACHMAN, R.L., JAFFE, E.A. and COLEMAN, M. A clinical study of the Lupus Anticoagulant. Blood 48, 499-509, 1976.
35. TRIPLETT D.A., BRANDT, J.T., KALZOR, D. and SCHAEFFER, J. Laboratory diagnosis of Lupus Inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. AJCP 79, 678-682, 1983.
36. SOUTO, J.C., MARTINEZ, E., ROCA M., MATEO, J., PUJOL, J., CONDOMINES, J., GONZALEZ, D. and FONTCUBERTA, J. Low levels of plasminogen activator inhibitor type I in patients with inflammatory bowel disease. Fibrinolysis 8, 359-363, 1994.
37. EDWARDS, R.L., LEVINE, J.B., GREEN, R., DUFFY, M., MATHEWS, E., BRANDE, W. and RICKLES, F.R. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 92, 329-337, 1987.
38. WEBBERLEY, M.J., HART, M.T. and MELIKIAN, V. Thromboembolism in inflammatory bowel disease: role of platelets. Gut 34, 247-251, 1993.
39. ELIAKIM, R., KARMELI, F., RAZIN, E. and RACHMILEWITZ, D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 95, 1167-1172, 1988.
40. KALD, B., OLAISON, G., SJODAHL, R. and TAGESSON, C. Novel aspect of Crohn's disease: increased content of platelet-activating factor in ileal and colonic mucosa. Digestion 46, 199-204, 1990.
41. FERRARIS, L., KARMELI, F., ELIAKIM, R., KLEIN, J., FIOCCHI, C. and RACHMILEWITZ, D. Intestinal epitelial cell contribute to the enhanced generation of platelet activating factor in ulcerative colitis. Gut 34, 665-668, 1993.
42. COLLINS, C.E. and RAMPTON, D.S. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 36, 5-8, 1995.